Division of Pediatric Infectious Diseases, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Pediatr Infect Dis J. 2013 Apr;32(4):346-9. doi: 10.1097/INF.0b013e31827ee1c2.
Use of outpatient parenteral antimicrobial therapy (OPAT) in pediatrics is widespread and may be increasing. Recent data quantifying use and characteristics of pediatric OPAT are lacking.
To evaluate the number of children receiving OPAT each year and their associated characteristics and outcomes, we conducted a retrospective review of all patients discharged with OPAT from the Mayo Clinic Children's Hospital between August 1, 2010 and December 31, 2011.
During the study period, there were 126 pediatric hospital discharges with OPAT (2.5% of all discharges). OPAT was used most commonly to treat bone and joint (21%), bloodstream (15%), intra-abdominal (13%) and soft tissue (9%) infections. A positive culture or serology result was found in 86 (68%) OPAT courses. The most frequently used antibiotics were ceftriaxone (17%), cefazolin (16%) and cefepime (13%). The median duration of OPAT was 12 days. Thirty-six courses (29%) resulted in catheter- or antibiotic-associated complications. Weekly laboratory monitoring was more common when OPAT was managed by the infectious disease service (88%) versus other services (20%). Among 123 courses with follow-up, 109 (89%) resulted in cure, and 13 (11%) were treatment failures.
At our children's hospital, 2.5% of hospitalized patients were discharged with OPAT. In one-third of OPAT courses children developed catheter- or antibiotic-associated complications. Opportunities to increase the role of pediatric infectious disease in OPAT initiation and management should be explored.
小儿门诊静脉输注抗菌药物治疗(OPAT)的应用十分广泛,且可能呈上升趋势。目前缺乏对小儿 OPAT 使用情况和特点的量化数据。
为评估每年接受 OPAT 的患儿数量及其相关特征和结局,我们对 2010 年 8 月 1 日至 2011 年 12 月 31 日期间从梅奥诊所儿童医院出院接受 OPAT 的所有患者进行了回顾性研究。
研究期间,共有 126 例儿科住院患者接受 OPAT(占所有出院患者的 2.5%)。OPAT 最常用于治疗骨骼和关节(21%)、血流(15%)、腹腔(13%)和软组织(9%)感染。86 例(68%)OPAT 疗程中发现阳性培养或血清学结果。最常使用的抗生素为头孢曲松(17%)、头孢唑林(16%)和头孢吡肟(13%)。OPAT 的中位持续时间为 12 天。36 例(29%)疗程出现导管或抗生素相关并发症。当 OPAT 由感染科管理时(88%),比由其他科室管理时(20%)更常进行每周实验室监测。在 123 例有随访的疗程中,109 例(89%)治愈,13 例(11%)治疗失败。
在我们的儿童医院,2.5%的住院患者出院时接受 OPAT。在三分之一的 OPAT 疗程中,患儿出现导管或抗生素相关并发症。应探索增加儿科感染科在 OPAT 启动和管理中的作用的机会。